DiagnoCure’s GCC Marker For The Staging Of Colorectal Cancer Discussed At Two Scientific Meetings
DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that its Guanylyl Cyclase C (GCC) marker for identifying colorectal cancer cells is being featured at two scientific meetings this [...]



